QA: Obseva SA in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001685316_2023_Obseva_SA.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001685316, Obseva SA

  xvar xval
0 AssetsCurrent 15,993,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 551,000
4 LiabilitiesCurrent 7,186,000
5 LiabilitiesNoncurrent 292,000
6 remainder_Liabilities 583,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 11,000
11 remainder_Revenues 19,637,000
12 remainder_NetIncome -49,505,000
13 remainder_ComprehensiveNetIncome 6,340,000
  yvar yval
0 Assets 16,544,000
1 Liabilities 8,061,000
2 Expenses 11,000
3 Revenues 19,637,000
4 StockholdersEquity 8,483,000
5 NetIncome -29,879,000
6 ComprehensiveNetIncome -26,709,000
7 BaseVar 50,049,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.668
9 EconomicCapitalRatio 1.36

Edgar->Model Mapping

Feature Distribution